Related Experiment Video
Updated: Aug 13, 2026

08:40
Surgical Technique of the 3-Dimensional-printed Personalized Hip Implant for the Treatment of Canine Hip Dysplasia
Published on: April 19, 2024
Calvarial hyperostosis syndrome in two bullmastiffs
J F McConnell1, A Hayes, S R Platt
1Animal Health Trust, Lanwades Park, Kentford, Newmarket Suffolk CB8 7UU, UK. fraser.mcconnell@aht.org.uk
Summary
This study documents the first female bullmastiffs with calvarial hyperostosis syndrome, noting similar clinical and radiological signs as males. Magnetic resonance imaging revealed characteristic bone and soft tissue abnormalities.
Area of Science:
- Veterinary Medicine
- Canine Pathology
- Radiology
Background:
- Calvarial hyperostosis syndrome (CHS) is a rare condition affecting bone growth.
- Previously documented cases of CHS in bullmastiffs have been exclusively in males.
Purpose of the Study:
- To describe the clinical, radiological, and magnetic resonance (MR) imaging features of calvarial hyperostosis syndrome in two female bullmastiffs.
- To report the first documented cases of CHS in female dogs of this breed.
Main Methods:
- Clinical examination and standard radiography were performed on two affected bullmastiffs.
- Magnetic resonance (MR) imaging was utilized in one case to assess intracranial and surrounding soft tissue structures.
- Radiographic findings of long bones were also evaluated.
Main Results:
- The two bullmastiffs were diagnosed with calvarial hyperostosis syndrome, representing the first reported instances in females.
- Clinical and radiographic presentations were consistent with previously reported male cases.
- MR imaging revealed frontal bone thickening, loss of normal fat signal, and adjacent soft tissue abnormalities.
- One dog exhibited long bone changes in the femora, similar to those observed in craniomandibular osteopathy.
Conclusions:
- Calvarial hyperostosis syndrome affects female bullmastiffs similarly to males.
- MR imaging provides valuable insights into the characteristic bone and soft tissue changes associated with CHS.
- The findings expand the understanding of CHS presentation and potential long bone involvement in canines.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

